US20020040713A1 - Dry powder inhaler - Google Patents

Dry powder inhaler Download PDF

Info

Publication number
US20020040713A1
US20020040713A1 US10/007,617 US761701A US2002040713A1 US 20020040713 A1 US20020040713 A1 US 20020040713A1 US 761701 A US761701 A US 761701A US 2002040713 A1 US2002040713 A1 US 2002040713A1
Authority
US
United States
Prior art keywords
inhaler
housing
chamber
duct
staging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/007,617
Inventor
Robert Eisele
Karen Davies
Nelson Holton
Tim Kline
Ian Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dura Pharmaceuticals Inc
Original Assignee
Dura Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/428,960 external-priority patent/US5622166A/en
Application filed by Dura Pharmaceuticals Inc filed Critical Dura Pharmaceuticals Inc
Priority to US10/007,617 priority Critical patent/US20020040713A1/en
Publication of US20020040713A1 publication Critical patent/US20020040713A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0005Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • A61M15/0025Mouthpieces therefor with caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0024Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with an on-off output signal, e.g. from a switch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated

Definitions

  • the field of the invention is inhalers. More specifically, the invention relates to inhalers for delivering drugs in a solid finely divided dry powder or fluid form.
  • Inhalers are used to deliver drugs into a patient's lungs.
  • an inhaler typically contains or provides a mixture of drugs and air or propellants.
  • the mixture is delivered via the patient inhaling from a mouthpiece on the inhaler, for treatment of various conditions, for example, bronchial asthma.
  • delivery of drugs via inhalation can be used for many other treatments, including those unrelated to lung condition.
  • the present inhaler preferably includes a cover plate pivotably attached to a lid on an inhaler housing.
  • a blister pack disk is rotatably mounted on the housing under the cover plate, and is movable in a single forward direction.
  • An actuator in the housing is most desirably aligned with a lever on the cover plate. The patient pushes the actuator which shears open a blister on the disk and then causes the lever to crush the blister, to deliver the drug powder contents of the blister into a duct within the housing, for subsequent inhalation by the patient.
  • FIG. 1 is perspective view of the present inhaler with the mouthpiece covered by the cover assembly
  • FIG. 2 is a perspective view thereof with the mouthpiece uncovered
  • FIG. 3 is a plan view of the inhaler as shown in FIG. 1;
  • FIG. 4 is a plan view of the inhaler as shown in FIG. 2;
  • FIG. 5 is an exploded perspective view of the inhaler of FIGS. 1 and 2;
  • FIG. 6 is an plan view of the inhaler of FIGS. 1 and 2 with the lid open;
  • FIG. 7 is a partial section view taken along line 7 - 7 of FIG. 6;
  • FIG. 8 is an enlarged top and front perspective view of the cover assembly on the inhalers of FIGS. 1 and 2;
  • FIG. 9 is a bottom and rear perspective view of the cover assembly of FIG. 8;
  • FIG. 10 is an enlarged view of features shown in FIG. 9;
  • FIG. 11 is a partial section view taken along line 11 - 11 of FIG. 5;
  • FIG. 12 is similar view showing positions of various components during use of the device.
  • FIG. 13 is a partial section view taken along line 13 - 13 of FIG. 3;
  • FIG. 14 is a partial section view taken along line 14 - 14 of FIG. 4;
  • FIGS. 15, 16 and 17 are partial section view fragments illustrating movement of components within the device
  • FIG. 18 is a section view taken along line 18 - 18 of FIG. 5;
  • FIG. 19 is a similar view thereof with various components omitted for drawing clarity, and showing positions of components during use;
  • FIG. 20 is an exploded perspective view of a blister disk for use with the inhaler shown in FIGS. 1 and 2;
  • FIG. 21 is a partial plan view thereof.
  • FIG. 22 is a section view taken along line 22 - 22 of FIG. 21.
  • a dry powder inhaler includes a housing 32 having a lid 38 attached to the housing with a hinge 36 .
  • the lid 38 is preferably a transparent material, e.g., clear plastic.
  • a removable mouthpiece 34 is provided on one side of the housing 32 .
  • a sliding cover assembly 40 may be pivoted on the lid 38 from a closed position covering the mouthpiece 34 , as shown in FIGS. 1 and 3, to an opened position exposing the mouthpiece 34 , as shown in FIGS. 2 and 4. As best shown in FIGS.
  • a disk 42 having a plurality of radially spaced apart blisters 44 is generally centered on top of the housing 32 on a center post 140 extending upwardly from the housing 32 .
  • a lid stop 46 on the housing 32 limits sliding movement of the cover assembly 40 in the opened position.
  • the sliding cover assembly 40 includes an enclosure 48 having a front curved wall 54 , a side wall 56 , a top wall 58 and a bottom wall 60 .
  • a rim 62 extends upwardly and radially inwardly on the top wall 58 .
  • a glide block 64 and an outside retainer 66 extend downwardly and inwardly on the underside of the top wall 58 .
  • a generally flat cover plate 50 is preferably integrally formed with the enclosure 48 , with the cover plate 50 and enclosure comprising the cover assembly 40 .
  • An inside retainer 68 on the cover plate 50 extends radially outwardly.
  • a lever 74 is pivotably supported on a lever pin 76 held in place by lever blocks 72 on the underside of the cover plate 50 .
  • the lever 74 can pivot through a lever opening 78 in the cover plate 50 , as best shown in FIG. 8.
  • a ramp 80 and a guide wall 82 project downwardly from the cover plate 50 , adjacent to the lever 74 , as shown in FIG. 9.
  • the entire cover assembly 40 which includes the enclosure 48 and cover plate 50 is pivotably attached to the lid 38 , with the lid post 52 extending through a center hub 84 on the cover plate 50 .
  • Clearance holes 70 through the cover plate 50 on either side of the lever opening 78 allow the cover plate to sit on top of the blister disk, as shown in FIG. 18, without excessive vertical interference.
  • a spring arm 86 having a downwardly projecting end tab 88 is attached to or integral with the cover plate 50 .
  • the spring arm 86 includes an arm wedge 96 at its free end, alongside the tab 88 .
  • an arm lifter 102 extends downwardly from the lid 38 .
  • An outer slot 94 through the cover plate 50 overlies the spring arm 86 .
  • An inner slot 92 adjoining the outer slot 94 through the cover plate 50 provides clearance for the arm lifter 102 , and allows the cover assembly 40 to rotate (preferably about 90°).
  • the arm lifter 102 includes an internal ramp, and is dimensioned to engage the arm wedge 96 , and lift the arm 86 up towards the lid 38 , as the arm wedge 96 moves into full engagement with the lifter 102 .
  • the housing 32 includes a mixing chamber 120 , and a staging chamber 124 connected to the mixing chamber 120 via a duct 122 .
  • an inlet duct 126 extends from one side of the housing 32 to the staging chamber 124 via a duct recess 130 .
  • a crescent barrier 128 around the top of the staging chamber 124 creates an indirect air flow path from outside of the housing, through the inlet duct 126 and into the staging chamber 124 .
  • a pressure port or opening 132 in the housing 32 alongside the mixing chamber 120 connects to a pressure switch 170 via a tube 172 .
  • the pressure port aligns with a mouthpiece port 135 leading into the central opening of the mouthpiece. This provides a continuous duct from the mouthpiece opening to the pressure switch.
  • the mouthpiece 34 or an alternative embodiment mouthpiece 136 is secured to the housing 32 with a hook 134 .
  • the mouthpiece is removable by twisting or rotating the mouthpiece, to disengage the hook 134 , and then by pulling it off.
  • Rachet posts 142 having angled top surfaces project slightly above the flat top surface 138 of the housing 32 .
  • An actuation button 146 has a post 148 extending entirely through a post opening 144 in the housing 32 .
  • a detent 145 on the housing engages and holds the post 148 in the up position (driving the lever to crush a blister), until the disk is advanced to the next blister.
  • At the front of the housing, behind the mixing chamber 120 is an inwardly projecting housing inner rim 150 , and an outwardly projecting housing outer rim 152 .
  • the outer rim 152 is engaged by the outside retainer 66
  • the inner rim is engaged by the inside retainer 68 , as the cover assembly 40 is moved between opened and closed positions.
  • the interaction of the inner rim 150 and inside retainer 68 and outer rim 152 and outside retainer 66 holds the cover assembly and lid down on top of the housing 32 .
  • a bottom cover 158 attached to the housing 32 has a button recess 164 around the actuation button 146 , so that the actuation button 146 does not project beyond the bottom surface of the cover 158 .
  • An impeller 162 within the mixing chamber 120 is supported on the shaft of an electric motor 160 behind the mixing chamber 120 in the housing 32 .
  • the motor 160 is wired to batteries 168 and the pressure switch 170 .
  • a battery indicator LED 174 and a status indicator LED 176 are positioned in the housing 32 , above the pressure switch 170 .
  • the disk 42 includes a blister foil ring 190 , preferably a metal or aluminum foil having generally conical blisters formed in it.
  • the blister foil ring 190 and a foil seal ring 192 are adhered or bonded onto a carrier disk 194 .
  • the carrier disk 194 has tabs 196 suspended within tab slots 198 by bridges 200 .
  • Each blister 44 on the blister foil ring 190 is aligned over a tab 196 .
  • the bridges 200 hold the tabs 196 in position, but allow the tab to pivot about the bridges, with nominal torque.
  • powdered drug 202 is sealed within the blisters 44 .
  • the carrier disk 194 is preferably plastic.
  • the tab supports 200 are small enough to support the tabs 196 , but also to allow the tab to pivot under force of the post of the actuation button.
  • a disk 42 is first loaded into the inhaler 30 by sliding the cover assembly 40 from the closed position shown in FIG. 1 to the open position shown in FIG. 2. In this position, the lid 38 and cover assembly 40 are still held down on top of the housing 32 by the interaction of the outside retainer 66 and inside retainer 68 on the housing outer rim 152 and inner rim 150 . The side wall 56 of the enclosure 48 is lifted slightly away from the housing 32 , to a allow it to pass over the lid stop 46 . As this occurs, the retainers 66 and 68 move off of and release from the inner and outer rims 150 and 152 . The cover assembly 40 and lid 38 are then pivoted upwardly about the hinge 36 , to open up the inhaler 30 , as shown in FIG. 6, for placement or replacement of a disk 42 .
  • a disk 42 is placed over the center post 140 over the housing top surface 138 with the blisters 44 on top.
  • the lid 38 and cover assembly 40 are pivoted back about the hinge 36 , from the position shown in FIG. 6, to the position shown in FIG. 2.
  • the inhaler 30 is then ready for use.
  • the rachet posts 142 on the housing top surface 138 project slightly into the open ends 203 of the tab slots 198 .
  • the disk 42 is accordingly oriented so that a blister 44 will be aligned over the staging chamber 124 .
  • the rachet posts 142 also prevent the disk 42 from moving in reverse (i.e., clockwise in FIG. 6).
  • the actuation button 146 With the inhaler 30 preferably held upright, the actuation button 146 is pushed up. As shown in FIGS. 11, 12 and 19 , the upward movement of the post 148 on the actuation button 146 first pivots the tab 196 on the blister 44 over the staging chamber 124 . The tab pivots on the bridges 200 . As this occurs, the foil seal ring 192 sealing the blister 44 on the bottom shears away opening the blister and allowing the powdered drug 202 to fall into the staging chamber 124 .
  • the patient places the mouthpiece 34 into the mouth and inhales.
  • the inhalation draws air from outside of the housing through the inlet duct 126 , around and under the crescent barrier 128 and into the staging chamber 124 .
  • Air and powdered drug 202 move through the duct 122 and into the mixing chamber 120 .
  • the reduced air pressure at the mouthpiece 136 is detected by the pressure switch 170 via the tube 172 extending to the pressure port 132 .
  • the switch 170 turns on the motor 160 , spinning the impeller 162 within the mixing chamber 120 .
  • the air and drug is mixed in the mixing chamber 120 , as further described in U.S. Pat. Nos. 5,327,883, and 5,577,497, incorporated herein by reference.
  • the impeller is already spinning at high speed when the drug enters the mixing chamber, the air/drug mixing and deagglomeration are enhanced.
  • the cover assembly 40 is moved from the position shown in FIG. 2, to the position shown in FIG. 1, to cover the mouthpiece 34 .
  • the arm wedge 96 on the spring arm 86 is released from the lifter 102 .
  • This allows the spring arm 86 to flex downwardly with the tab 88 engaging into the opened end 202 of a tab slot 198 , approximately at position A as shown in FIGS. 3 and 6.
  • the tab 88 on the spring arm 86 advances the disk 42 to the next blister 44 (moving the disk 42 counter-clockwise in FIG. 3).
  • the advancing movement, from engagement of the tab 88 to the disk 42 , until the end of movement, is about 22°.
  • the disk 42 rides up and over the angled top surfaces of the rachet posts 142 and then settles back down onto the housing surface 138 with the rachet posts 142 engaged into the next set of opened ends 203 of the tab slots 198 .
  • the next blister 44 on the disk 42 is positioned for delivery and inhalation, as described above.
  • the disk 42 does not move, as the spring arm 86 is lifted up and out from engagement with the disk by the interaction of the lifter 102 on the lid 38 and the arm wedge 96 on the spring arm 86 .
  • each blister 44 on the disk 42 can be sequentially accessed, until all of the blisters are used.
  • the ramp 80 on the cover plate 50 rides over the top of the post 148 , the push it down, resetting the actuation button 146 for the next dose, as shown in FIGS. 15 - 17 .
  • the guide wall 82 which ramps upwardly from the lever 74 , pushes down on the pivoted tab 196 from the blister delivered.
  • the tab 196 is accordingly pushed back down into the plane of the disk 42 , so that the disk can be advanced without interference.
  • the rachet posts 142 prevent the disk 42 from moving in reverse (clockwise in FIG. 3) at anytime.

Abstract

A drug powder inhaler has a cover plate pivotably attached to a lid on an inhaler housing. A lever is pivotably attached to the cover plate. A blister pack disk is rotatably mounted on the housing under the cover plate. A powder duct in the housing extends from a staging chamber underneath one end of the lever to an aerosolizing chamber. An actuator in the housing is pressed to shear open a blister on the blister pack disk and thereby deliver the drug dose contents of the blister into the staging chamber. A switch senses pressure in the mouthpiece and switches on a motor spinning an impeller within the aerosolizing chamber, when inhalation is detected.

Description

    BACKGROUND OF THE INVENTION
  • This application is a continuation of U.S. patent application Ser. No. 09/351,895, filed Jul. 13, 1999, and now pending, which is a continuation-in-part of application Ser. No. 08/428,960, filed Apr. 24, 1995 and now U.S. Pat. No. 5,622,166, and incorporated herein by reference. [0001]
  • FIELD OF THE INVENTION
  • The field of the invention is inhalers. More specifically, the invention relates to inhalers for delivering drugs in a solid finely divided dry powder or fluid form. [0002]
  • Inhalers are used to deliver drugs into a patient's lungs. Typically, an inhaler contains or provides a mixture of drugs and air or propellants. The mixture is delivered via the patient inhaling from a mouthpiece on the inhaler, for treatment of various conditions, for example, bronchial asthma. However, delivery of drugs via inhalation can be used for many other treatments, including those unrelated to lung condition. [0003]
  • One well known inhaler, the Diskhaler, described in U.S. with each successive dose. However, while the device described in U.S. Pat. No. 4,627,432 has met with varying degrees of success, disadvantages remain in indexing or advancing a blister disk within an inhaler, with opening the blisters to access the drug contents, with reliably providing intended dosages, and in other areas. [0004]
  • Accordingly, it is an object of the invention to provide an improved inhaler. [0005]
  • SUMMARY OF THE INVENTION
  • To these ends, the present inhaler preferably includes a cover plate pivotably attached to a lid on an inhaler housing. A blister pack disk is rotatably mounted on the housing under the cover plate, and is movable in a single forward direction. An actuator in the housing is most desirably aligned with a lever on the cover plate. The patient pushes the actuator which shears open a blister on the disk and then causes the lever to crush the blister, to deliver the drug powder contents of the blister into a duct within the housing, for subsequent inhalation by the patient. [0006]
  • Other and further objects will appear hereinafter.[0007]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the drawings, wherein similar reference characters denote similar elements throughout the several views: [0008]
  • FIG. 1 is perspective view of the present inhaler with the mouthpiece covered by the cover assembly; [0009]
  • FIG. 2 is a perspective view thereof with the mouthpiece uncovered; [0010]
  • FIG. 3 is a plan view of the inhaler as shown in FIG. 1; [0011]
  • FIG. 4 is a plan view of the inhaler as shown in FIG. 2; [0012]
  • FIG. 5 is an exploded perspective view of the inhaler of FIGS. 1 and 2; [0013]
  • FIG. 6 is an plan view of the inhaler of FIGS. 1 and 2 with the lid open; [0014]
  • FIG. 7 is a partial section view taken along line [0015] 7-7 of FIG. 6;
  • FIG. 8 is an enlarged top and front perspective view of the cover assembly on the inhalers of FIGS. 1 and 2; [0016]
  • FIG. 9 is a bottom and rear perspective view of the cover assembly of FIG. 8; [0017]
  • FIG. 10 is an enlarged view of features shown in FIG. 9; [0018]
  • FIG. 11 is a partial section view taken along line [0019] 11-11 of FIG. 5;
  • FIG. 12 is similar view showing positions of various components during use of the device; [0020]
  • FIG. 13 is a partial section view taken along line [0021] 13-13 of FIG. 3;
  • FIG. 14 is a partial section view taken along line [0022] 14-14 of FIG. 4;
  • FIGS. 15, 16 and [0023] 17 are partial section view fragments illustrating movement of components within the device;
  • FIG. 18 is a section view taken along line [0024] 18-18 of FIG. 5;
  • FIG. 19 is a similar view thereof with various components omitted for drawing clarity, and showing positions of components during use; [0025]
  • FIG. 20 is an exploded perspective view of a blister disk for use with the inhaler shown in FIGS. 1 and 2; [0026]
  • FIG. 21 is a partial plan view thereof; and [0027]
  • FIG. 22 is a section view taken along line [0028] 22-22 of FIG. 21.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Turning now in detail to the drawings, as shown in FIGS. [0029] 1-4, a dry powder inhaler includes a housing 32 having a lid 38 attached to the housing with a hinge 36. The lid 38 is preferably a transparent material, e.g., clear plastic. A removable mouthpiece 34 is provided on one side of the housing 32. A sliding cover assembly 40 may be pivoted on the lid 38 from a closed position covering the mouthpiece 34, as shown in FIGS. 1 and 3, to an opened position exposing the mouthpiece 34, as shown in FIGS. 2 and 4. As best shown in FIGS. 3 and 4 (looking down through the transparent lid 38), a disk 42 having a plurality of radially spaced apart blisters 44 is generally centered on top of the housing 32 on a center post 140 extending upwardly from the housing 32. A lid stop 46 on the housing 32 limits sliding movement of the cover assembly 40 in the opened position.
  • Turning momentarily to FIGS. 8 and 9, the sliding [0030] cover assembly 40 includes an enclosure 48 having a front curved wall 54, a side wall 56, a top wall 58 and a bottom wall 60. A rim 62 extends upwardly and radially inwardly on the top wall 58.
  • Referring now to FIG. 9, a glide block [0031] 64 and an outside retainer 66 extend downwardly and inwardly on the underside of the top wall 58. A generally flat cover plate 50 is preferably integrally formed with the enclosure 48, with the cover plate 50 and enclosure comprising the cover assembly 40. An inside retainer 68 on the cover plate 50 extends radially outwardly. A lever 74 is pivotably supported on a lever pin 76 held in place by lever blocks 72 on the underside of the cover plate 50. The lever 74 can pivot through a lever opening 78 in the cover plate 50, as best shown in FIG. 8. A ramp 80 and a guide wall 82 project downwardly from the cover plate 50, adjacent to the lever 74, as shown in FIG. 9. The entire cover assembly 40, which includes the enclosure 48 and cover plate 50 is pivotably attached to the lid 38, with the lid post 52 extending through a center hub 84 on the cover plate 50. Clearance holes 70 through the cover plate 50 on either side of the lever opening 78 allow the cover plate to sit on top of the blister disk, as shown in FIG. 18, without excessive vertical interference.
  • Referring to FIGS. 8, 9 and [0032] 10, a spring arm 86 having a downwardly projecting end tab 88 is attached to or integral with the cover plate 50. As shown in FIG. 13, the spring arm 86 includes an arm wedge 96 at its free end, alongside the tab 88. As shown in FIG. 10, an arm lifter 102 extends downwardly from the lid 38. An outer slot 94 through the cover plate 50 overlies the spring arm 86. An inner slot 92 adjoining the outer slot 94 through the cover plate 50 provides clearance for the arm lifter 102, and allows the cover assembly 40 to rotate (preferably about 90°). The arm lifter 102 includes an internal ramp, and is dimensioned to engage the arm wedge 96, and lift the arm 86 up towards the lid 38, as the arm wedge 96 moves into full engagement with the lifter 102.
  • Turning now to FIG. 5, the [0033] housing 32 includes a mixing chamber 120, and a staging chamber 124 connected to the mixing chamber 120 via a duct 122. Referring now also to FIGS. 6 and 7, an inlet duct 126 extends from one side of the housing 32 to the staging chamber 124 via a duct recess 130. A crescent barrier 128 around the top of the staging chamber 124 creates an indirect air flow path from outside of the housing, through the inlet duct 126 and into the staging chamber 124.
  • In a first embodiment of the present invention, referring once again to FIG. 5, a pressure port or opening [0034] 132 in the housing 32 alongside the mixing chamber 120 connects to a pressure switch 170 via a tube 172. The pressure port aligns with a mouthpiece port 135 leading into the central opening of the mouthpiece. This provides a continuous duct from the mouthpiece opening to the pressure switch. The mouthpiece 34 or an alternative embodiment mouthpiece 136 is secured to the housing 32 with a hook 134. The mouthpiece is removable by twisting or rotating the mouthpiece, to disengage the hook 134, and then by pulling it off. Rachet posts 142 having angled top surfaces project slightly above the flat top surface 138 of the housing 32. An actuation button 146 has a post 148 extending entirely through a post opening 144 in the housing 32.
  • Referring momentarily to FIG. 18, a [0035] detent 145 on the housing engages and holds the post 148 in the up position (driving the lever to crush a blister), until the disk is advanced to the next blister. At the front of the housing, behind the mixing chamber 120, is an inwardly projecting housing inner rim 150, and an outwardly projecting housing outer rim 152. The outer rim 152 is engaged by the outside retainer 66, and the inner rim is engaged by the inside retainer 68, as the cover assembly 40 is moved between opened and closed positions. The interaction of the inner rim 150 and inside retainer 68 and outer rim 152 and outside retainer 66, holds the cover assembly and lid down on top of the housing 32.
  • Referring still to FIG. 5, a [0036] bottom cover 158 attached to the housing 32 has a button recess 164 around the actuation button 146, so that the actuation button 146 does not project beyond the bottom surface of the cover 158. An impeller 162 within the mixing chamber 120 is supported on the shaft of an electric motor 160 behind the mixing chamber 120 in the housing 32. The motor 160 is wired to batteries 168 and the pressure switch 170. A battery indicator LED 174 and a status indicator LED 176 are positioned in the housing 32, above the pressure switch 170.
  • Turning now to FIGS. [0037] 20-22, the disk 42 includes a blister foil ring 190, preferably a metal or aluminum foil having generally conical blisters formed in it. The blister foil ring 190 and a foil seal ring 192 are adhered or bonded onto a carrier disk 194. As shown in FIG. 21, the carrier disk 194 has tabs 196 suspended within tab slots 198 by bridges 200. Each blister 44 on the blister foil ring 190 is aligned over a tab 196. The bridges 200 hold the tabs 196 in position, but allow the tab to pivot about the bridges, with nominal torque. As shown in FIG. 22, powdered drug 202 is sealed within the blisters 44. The carrier disk 194 is preferably plastic. The tab supports 200 are small enough to support the tabs 196, but also to allow the tab to pivot under force of the post of the actuation button.
  • In use, a [0038] disk 42 is first loaded into the inhaler 30 by sliding the cover assembly 40 from the closed position shown in FIG. 1 to the open position shown in FIG. 2. In this position, the lid 38 and cover assembly 40 are still held down on top of the housing 32 by the interaction of the outside retainer 66 and inside retainer 68 on the housing outer rim 152 and inner rim 150. The side wall 56 of the enclosure 48 is lifted slightly away from the housing 32, to a allow it to pass over the lid stop 46. As this occurs, the retainers 66 and 68 move off of and release from the inner and outer rims 150 and 152. The cover assembly 40 and lid 38 are then pivoted upwardly about the hinge 36, to open up the inhaler 30, as shown in FIG. 6, for placement or replacement of a disk 42.
  • A [0039] disk 42 is placed over the center post 140 over the housing top surface 138 with the blisters 44 on top. The lid 38 and cover assembly 40 are pivoted back about the hinge 36, from the position shown in FIG. 6, to the position shown in FIG. 2. The inhaler 30 is then ready for use.
  • The rachet posts [0040] 142 on the housing top surface 138 project slightly into the open ends 203 of the tab slots 198. The disk 42 is accordingly oriented so that a blister 44 will be aligned over the staging chamber 124. The rachet posts 142 also prevent the disk 42 from moving in reverse (i.e., clockwise in FIG. 6).
  • With the [0041] lid 38 closed, but with the cover assembly 40 opened (as shown in FIG. 2), the inner end of the lever 74 is aligned over the top of the post 148. The outer end of the lever 74 is aligned over the top of a blister 44, and over the staging chamber 124.
  • With the [0042] inhaler 30 preferably held upright, the actuation button 146 is pushed up. As shown in FIGS. 11, 12 and 19, the upward movement of the post 148 on the actuation button 146 first pivots the tab 196 on the blister 44 over the staging chamber 124. The tab pivots on the bridges 200. As this occurs, the foil seal ring 192 sealing the blister 44 on the bottom shears away opening the blister and allowing the powdered drug 202 to fall into the staging chamber 124.
  • As upward movement of the [0043] post 148 continues, the post pivots the lever 74 causing the outer end of the lever to crush the blister 44 down, to release any residual powder into the staging chamber 124.
  • With one dose of the powdered drug now delivered from a sealed [0044] blister 44 into the staging chamber 124, the patient places the mouthpiece 34 into the mouth and inhales. The inhalation draws air from outside of the housing through the inlet duct 126, around and under the crescent barrier 128 and into the staging chamber 124. Air and powdered drug 202 move through the duct 122 and into the mixing chamber 120. At the same time, upon inhalation, the reduced air pressure at the mouthpiece 136 is detected by the pressure switch 170 via the tube 172 extending to the pressure port 132. The switch 170 turns on the motor 160, spinning the impeller 162 within the mixing chamber 120. The air and drug is mixed in the mixing chamber 120, as further described in U.S. Pat. Nos. 5,327,883, and 5,577,497, incorporated herein by reference. As the impeller is already spinning at high speed when the drug enters the mixing chamber, the air/drug mixing and deagglomeration are enhanced.
  • The patient inhales on the mouthpiece drawing in the air/drug mixture from the mixing [0045] chamber 120 via holes 125 in the rear wall of the mouthpiece 34 (which rear wall also forms the front wall of the mixing chamber 120).
  • To prepare for delivery of the next dose, the [0046] cover assembly 40 is moved from the position shown in FIG. 2, to the position shown in FIG. 1, to cover the mouthpiece 34. As this closing movement of the cover assembly 40 occurs, the arm wedge 96 on the spring arm 86 is released from the lifter 102. This allows the spring arm 86 to flex downwardly with the tab 88 engaging into the opened end 202 of a tab slot 198, approximately at position A as shown in FIGS. 3 and 6. With the continued closing motion of the cover assembly 40 to the position shown in FIG. 3, the tab 88 on the spring arm 86 advances the disk 42 to the next blister 44 (moving the disk 42 counter-clockwise in FIG. 3). For a disk having 16 blisters, the advancing movement, from engagement of the tab 88 to the disk 42, until the end of movement, is about 22°. As the disk 42 is advanced by the spring arm 86 on the closing cover assembly 40, the disk 42 rides up and over the angled top surfaces of the rachet posts 142 and then settles back down onto the housing surface 138 with the rachet posts 142 engaged into the next set of opened ends 203 of the tab slots 198. In this manner, the next blister 44 on the disk 42 is positioned for delivery and inhalation, as described above. When the cover assembly 40 is reopened, to the position shown in FIG. 4, the disk 42 does not move, as the spring arm 86 is lifted up and out from engagement with the disk by the interaction of the lifter 102 on the lid 38 and the arm wedge 96 on the spring arm 86. Through this repeated motion of opening and closing the cover assembly 40, each blister 44 on the disk 42 can be sequentially accessed, until all of the blisters are used.
  • As the [0047] cover assembly 40 is closed, the ramp 80 on the cover plate 50 rides over the top of the post 148, the push it down, resetting the actuation button 146 for the next dose, as shown in FIGS. 15-17. Simultaneously, the guide wall 82, which ramps upwardly from the lever 74, pushes down on the pivoted tab 196 from the blister delivered. The tab 196 is accordingly pushed back down into the plane of the disk 42, so that the disk can be advanced without interference. The rachet posts 142 prevent the disk 42 from moving in reverse (clockwise in FIG. 3) at anytime.
  • Accordingly, a novel inhaler is described and shown with various advantages over the prior art design. The above-described inhaler may contain various changes and modifications, including various substitutions and equivalents, without departing from the spirit and scope of the present invention. [0048]

Claims (18)

We claim:
1. An inhaler comprising:
a housing;
a staging chamber in the housing, with the staging chamber having an open top, to allow a dose of a dry powder pharmaceutical to move via gravity into the staging chamber from a dose carrier above the staging chamber, and with the staging chamber having a substantially closed bottom end to allow the staging chamber to temporarily hold the dose of dry powder;
a mixing chamber in the housing spaced apart from the staging chamber; and
an enclosed continuous duct extending from the staging chamber to the mixing chamber.
2. The inhaler of claim 1 further comprising an inlet extending into the housing to the staging chamber.
3. The inhaler of claim 1 further comprising a barrier between the staging chamber and the inlet.
4. The inhaler of claim 1 further comprising means for opening the dose carrier aligned above the staging chamber.
5. The inhaler of claim 1 wherein the enclosed duct extends substantially horizontally in the housing.
6. The inhaler of claim 1 wherein the duct and the mixing chamber have round cross sections, and the diameter of mixing chamber is greater than the diameter of the duct.
7. An inhaler comprising:
a housing;
an air flow path extending through the housing and comprising:
an inlet extending into the housing;
a staging chamber within the housing with the inlet joining into the staging chamber;
a mixing chamber within the housing;
a duct in the housing having a first end connecting into the staging chamber and having a second end connecting into the mixing chamber.
8. The inhaler of claim 7 further comprising a mouthpiece forming a wall of the mixing chamber.
9. The inhaler of claim 7 with the mixing chamber having a circumferential wall between flat first and second walls, and wherein the duct connects into the mixing chamber through the first flat wall.
10. The inhaler of claim 7 wherein the staging chamber has an open top for receiving a dose of power via gravity.
11. The inhaler of claim 9 wherein the circumferential wall has a diameter greater than the diameter of the duct.
12. The inhaler of claim 7 wherein the staging chamber has a closed off bottom surface and an open top end.
13. The inhaler of claim 12 wherein the duct connects into the staging chamber adjacent to the closed off bottom surface.
14. The inhaler of claim 7 further including a mouthpiece connecting to the mixing chamber and wherein the duct provides the only connection between the staging chamber and the mixing chamber, such that all air entering into the mixing chamber via the duct, upon inhalation on the mouthpiece by a user of the inhaler, comes from the staging chamber.
15. The inhaler of claim 7 wherein the duct has a round cross section.
16. The inhaler of claim 15 wherein the duct has a length greater than its diameter.
17. The inhaler of claim 7 with the housing having a flat top surface and the duct extends in a direction parallel to the flat top surface.
18. The inhaler of claim 7 wherein the duct is longer than the inlet.
US10/007,617 1995-04-24 2001-11-07 Dry powder inhaler Abandoned US20020040713A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/007,617 US20020040713A1 (en) 1995-04-24 2001-11-07 Dry powder inhaler

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/428,960 US5622166A (en) 1995-04-24 1995-04-24 Dry powder inhaler delivery system
US08/681,103 US5921237A (en) 1995-04-24 1996-07-22 Dry powder inhaler
US09/351,895 US6328034B1 (en) 1996-07-22 1999-07-13 Dry powder inhaler
US10/007,617 US20020040713A1 (en) 1995-04-24 2001-11-07 Dry powder inhaler

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/351,895 Continuation US6328034B1 (en) 1995-04-24 1999-07-13 Dry powder inhaler

Publications (1)

Publication Number Publication Date
US20020040713A1 true US20020040713A1 (en) 2002-04-11

Family

ID=26997298

Family Applications (3)

Application Number Title Priority Date Filing Date
US08/681,103 Expired - Fee Related US5921237A (en) 1995-04-24 1996-07-22 Dry powder inhaler
US09/351,895 Expired - Fee Related US6328034B1 (en) 1995-04-24 1999-07-13 Dry powder inhaler
US10/007,617 Abandoned US20020040713A1 (en) 1995-04-24 2001-11-07 Dry powder inhaler

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/681,103 Expired - Fee Related US5921237A (en) 1995-04-24 1996-07-22 Dry powder inhaler
US09/351,895 Expired - Fee Related US6328034B1 (en) 1995-04-24 1999-07-13 Dry powder inhaler

Country Status (11)

Country Link
US (3) US5921237A (en)
EP (1) EP0925084A4 (en)
JP (1) JP2001507949A (en)
AU (1) AU729272B2 (en)
BR (1) BR9710880A (en)
CZ (1) CZ18999A3 (en)
HU (1) HUP9903819A3 (en)
IL (1) IL128030A0 (en)
NO (1) NO990272L (en)
NZ (2) NZ505722A (en)
WO (1) WO1998003217A1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040118399A1 (en) * 2002-12-18 2004-06-24 Elan Pharmaceutical Technologies Unit dose dry powder inhaler
US20050126562A1 (en) * 2003-12-15 2005-06-16 Alexza Molecular Delivery Corporation Treatment of breakthrough pain by drug aerosol inhalation
US20070154407A1 (en) * 2005-12-01 2007-07-05 Boehringer Ingelheim International Gmbh Inhaler and store for a dry medicament formulation and related methods and use thereof
US20070221218A1 (en) * 2003-10-27 2007-09-27 Warden Jeffrey A Dry Powder Drug Containment System Packages with Tabs, Inhalers and Associated Methods
US20070267015A1 (en) * 2006-05-18 2007-11-22 Boehringer Ingelheim International Gmbh Atomizer
US20070272235A1 (en) * 2004-02-19 2007-11-29 Akihiko Miyamoto Inhaler Aid With Reed for Minute Powdery Curative Medicine
US20080041368A1 (en) * 2004-08-16 2008-02-21 Glaxo Group Limited Medicament Dispenser
US20080196718A1 (en) * 2005-07-28 2008-08-21 Glaxo Group Limited Medicament Dispenser
EP2082772A1 (en) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
US7617822B2 (en) 2003-06-16 2009-11-17 Rijksuniversiteit Groningen Dry powder inhaler and method for pulmonary inhalation of dry powder
US20100059052A1 (en) * 2006-11-15 2010-03-11 Glaxo Group Limited Sheet driver for use in a drug dispenser
US20100078022A1 (en) * 2008-09-26 2010-04-01 Rachel Striebig Inhalers with airway disks having discrete airway channels and related disks and methods
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
US20110162648A1 (en) * 2008-09-26 2011-07-07 Ruckdeschel Thomas W Inhaler mechanisms with radially biased piercers and related methods
US20110174306A1 (en) * 2008-09-30 2011-07-21 David Harris Dry Powder Inhalers with Multi-Facet Surface Deagglomeration Chambers and Related Devices and Methods
US20110186047A1 (en) * 2008-10-01 2011-08-04 Scott Alexander Lewis Dry Powder Inhalers with Rotating Piercing Mechanisms and Related Devices and Methods
US8161968B2 (en) 2003-07-24 2012-04-24 Glaxo Group Limited Medicament dispenser
US8381721B2 (en) 2008-09-26 2013-02-26 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and related devices and methods
WO2014004256A1 (en) * 2012-06-25 2014-01-03 Respira Therapeutics, Inc. Powder dispersion devices and methods
US8997737B2 (en) 2003-10-17 2015-04-07 Vectura Delivery Devices Limited Inhaler
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
USD852408S1 (en) 2016-02-08 2019-06-25 Nicoventures Holdings Limited Electronic cigarette
US11040156B2 (en) 2015-07-20 2021-06-22 Pearl Therapeutics, Inc. Aerosol delivery systems
US11123501B2 (en) 2016-03-24 2021-09-21 Nicoventures Holdings Limited Electronic vapor provision system
US11213638B2 (en) 2016-03-24 2022-01-04 Nicoventures Trading Limited Vapor provision system
US11241043B2 (en) 2016-03-24 2022-02-08 Nicoventures Trading Limited Vapor provision apparatus
US11452826B2 (en) 2016-03-24 2022-09-27 Nicoventures Trading Limited Mechanical connector for electronic vapor provision system
US11471623B2 (en) 2012-02-21 2022-10-18 Respira Therapeutics, Inc. Powder dispersion methods and devices
US11524823B2 (en) 2016-07-22 2022-12-13 Nicoventures Trading Limited Case for a vapor provision device

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040237961A1 (en) * 1995-06-08 2004-12-02 Snow John Medlin Inhalation actuated device for use with metered dose inhalers (MDIs)
US6672304B1 (en) 1995-06-08 2004-01-06 Innovative Devices, Llc Inhalation actuated device for use with metered dose inhalers (MDIs)
US6470884B2 (en) 1996-01-29 2002-10-29 Aventis Pharma Limited Capsule opening arrangement for use in a powder inhaler
US6237590B1 (en) * 1997-09-18 2001-05-29 Delsys Pharmaceutical Corporation Dry powder delivery system apparatus
US6237591B1 (en) 1998-11-02 2001-05-29 Dura Pharmaceuticals, Inc. Turbine dry powder inhaler
US6655379B2 (en) 1998-03-16 2003-12-02 Nektar Therapeutics Aerosolized active agent delivery
SE9801114D0 (en) * 1998-03-30 1998-03-30 Astra Ab Inhalation device
DE19831525A1 (en) * 1998-07-14 2000-01-20 Pfeiffer Erich Gmbh & Co Kg Media Donor
GB9820937D0 (en) 1998-09-26 1998-11-18 Glaxo Group Ltd Inhalation device
GB9820886D0 (en) * 1998-09-26 1998-11-18 Glaxo Group Ltd Inhalation device
UA73924C2 (en) * 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
CA2725731A1 (en) * 1999-06-05 2000-12-14 Innovata Biomed Limited Delivery system
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6606992B1 (en) * 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US7464706B2 (en) * 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
GB9920839D0 (en) * 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
WO2001034234A1 (en) * 1999-11-11 2001-05-17 Dura Pharmaceuticals, Inc. Dry powder inhaler
GB9930602D0 (en) * 1999-12-24 2000-02-16 Glaxo Group Ltd Inhalation device
US6651655B1 (en) 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
US7069929B2 (en) * 2000-02-01 2006-07-04 Quadrant Technologies Limited Dry powder inhaler
WO2001078817A1 (en) * 2000-02-25 2001-10-25 Dura Pharmaceuticals, Inc. Dosing system for a dry powder inhaler
ES2305057T3 (en) 2000-02-28 2008-11-01 Pharmakodex Limited DEVICE FOR THE ADMINISTRATION OF ORAL PHARMACES.
AU2001250901A1 (en) * 2000-03-27 2001-10-08 Dura Pharmaceuticals, Inc. Containers for individual doses of an inhalable pharmaceutical
US6948494B1 (en) * 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
GB0015034D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
US7080644B2 (en) * 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
GB0015801D0 (en) * 2000-06-28 2000-08-16 Innovata Biomed Ltd Cover
GB0019715D0 (en) * 2000-08-10 2000-09-27 Pa Consulting Services Device for delivering physiologically active agent in powdered form
AU2001283546A1 (en) 2000-08-14 2002-02-25 Advanced Inhalation Research, Inc. Inhalation device and method
WO2002013886A2 (en) * 2000-08-15 2002-02-21 University Of Kentucky Research Foundation Programmable multi-dose intranasal drug delivery device
GB0026647D0 (en) 2000-10-31 2000-12-13 Glaxo Group Ltd Medicament dispenser
JP5154732B2 (en) * 2001-02-06 2013-02-27 イノバータ・バイオメッド・リミテッド Drug
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
ATE452617T1 (en) * 2001-04-19 2010-01-15 Technology Innovation Ltd MEDICINE CONTAINERS
GB0113881D0 (en) 2001-06-07 2001-08-01 Innovate Biomed Ltd Foil cutting system
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
CN1313171C (en) 2001-09-19 2007-05-02 埃德文特药物有限公司 An inhaler
GB0128148D0 (en) * 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
GB0130055D0 (en) * 2001-12-14 2002-02-06 Technology Innovation Ltd Medicament packaging
EP1494732B1 (en) 2002-03-20 2008-01-30 MannKind Corporation Inhalation apparatus
US7118010B2 (en) 2002-05-10 2006-10-10 Oriel Therapeutics, Inc. Apparatus, systems and related methods for dispensing and /or evaluating dry powders
DE60330776D1 (en) * 2002-05-10 2010-02-11 Oriel Therapeutics Inc DRY POWDER INHALER WITH A PIEZOELECTRIC POLYMER DRIVEN DISPENSER AND ASSOCIATED BLISTER PACKING WITH A PIEZOELECTRIC POLYMER MATERIAL
US6985798B2 (en) 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US7677411B2 (en) * 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7185651B2 (en) * 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
EP1535349B1 (en) * 2002-06-27 2014-06-25 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders
CA2506866A1 (en) * 2002-11-20 2004-06-03 Sun Pharmaceutical Industries Limited Dry powder inhaler
FR2849386B1 (en) 2002-12-27 2005-03-18 Bertin Technologies Sa INHALATION DEVICE FOR DRY POWDER
GB0303870D0 (en) * 2003-02-20 2003-03-26 Norton Healthcare Ltd Pre-metered dose magazine for breath-actuated dry powder inhaler
EP1603810B1 (en) * 2003-03-15 2010-08-11 Brin Tech International Limited Medicament package
GB0315509D0 (en) * 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
WO2005041848A2 (en) * 2003-10-27 2005-05-12 Oriel Therapeutics, Inc. Dry powder drug containment system packages with tabs, inhalers and associated methods
US7451761B2 (en) * 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
JP2007533387A (en) * 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド Inhaler
US7861712B2 (en) * 2004-04-23 2011-01-04 Manta Product Development Sealed capsule including an integrated puncturing mechanism
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE102004022796A1 (en) * 2004-05-08 2005-12-01 Arndt Muhle Inhaler unit takes the form of a hollow column which is provided with a mouthpiece, and is loaded with an inhalate in separate packages with removable lids
US20050263153A1 (en) * 2004-05-28 2005-12-01 Quadrant Technologies Limited Unit dose dry powder inhaler
US7556035B2 (en) * 2004-05-28 2009-07-07 Quadrant Technologies Limited Unit dose dry powder inhaler
DK1786784T3 (en) 2004-08-20 2011-02-14 Mannkind Corp Catalysis of diketopiperazine synthesis
PL2322180T3 (en) 2004-08-23 2015-10-30 Mannkind Corp Diketopiperazine salts for drug delivery
WO2006037636A2 (en) * 2004-10-06 2006-04-13 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing powder
JP2006130143A (en) * 2004-11-08 2006-05-25 Hitachi Ltd Inhalation administration device and medicine cartridge
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (en) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US7694676B2 (en) * 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT2594272T (en) 2005-05-18 2018-07-31 Horizon Orphan Llc Aerosolized fluoroquinolones and uses thereof
US8763605B2 (en) 2005-07-20 2014-07-01 Manta Devices, Llc Inhalation device
CN104324366B (en) 2005-09-14 2016-10-05 曼金德公司 Method for preparation of drug based on improving the active agent affinity to crystalline microparticle surfaces
MX360812B (en) 2006-02-22 2018-11-16 Mannkind Corp A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent.
DE102006014434A1 (en) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Packaging for multidose powder inhalers with optimized emptying properties
US8037880B2 (en) * 2006-04-07 2011-10-18 The University Of Western Ontario Dry powder inhaler
JP5241714B2 (en) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス, インコーポレイテッド Smart parenteral delivery system
US7726223B2 (en) * 2006-11-14 2010-06-01 Cb Products, Inc. Apparatus and methods for accessing packaged medicaments
US20080110453A1 (en) * 2006-11-15 2008-05-15 Delphi Technologies Inc. Nebulizer and methods for controlling the nebulizer
US20080110452A1 (en) * 2006-11-15 2008-05-15 Delphi Technologies Inc. Nebulizer and method for controlling an amount of liquid that is atomized by the nebulizer
US20080156320A1 (en) * 2007-01-03 2008-07-03 Thomas Low Ultrasonic nebulizer and method for atomizing liquid
US20080163610A1 (en) * 2007-01-05 2008-07-10 Matthew Thomas Baird Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
GB0704928D0 (en) * 2007-03-14 2007-04-25 Cambridge Consultants Dry powder inhalers
US8496002B2 (en) * 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
US11224704B2 (en) 2007-07-06 2022-01-18 Manta Devices, Llc Dose delivery device for inhalation
CN101795723B (en) 2007-07-06 2013-06-19 蒙塔设备有限公司 Inhalation devices for storing and delivering medicament
WO2009055733A1 (en) 2007-10-25 2009-04-30 Proteus Biomedical, Inc. Fluid transfer port information system
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
AU2008341217B2 (en) 2007-12-20 2012-04-12 Astrazeneca Ab Dispenser and method for entraining powder in an airflow 537
BRPI0906596A2 (en) * 2008-01-23 2015-07-07 Astrazeneca Ab Medicine-containing dispenser provided with a display to display markings to a user
EP2082764A1 (en) 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhaler
MX371521B (en) * 2008-03-27 2020-01-31 Mannkind Corp A dry powder inhalation system.
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DE202009018480U1 (en) 2008-06-13 2012-01-26 Mannkind Corp. Dry powder inhaler and drug delivery system
MX2010014240A (en) 2008-06-20 2011-03-25 Mankind Corp An interactive apparatus and method for real-time profiling of inhalation efforts.
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Use of ultrarapid acting insulin
CN105520922A (en) 2008-10-07 2016-04-27 拉普特制药有限公司 Aerosol fluoroquinolone formulations for improved pharmacokinetics
EP2346509B1 (en) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation of levofloxacin for reducing lung inflammation
GB201020130D0 (en) 2010-11-26 2011-01-12 Vectura Delivery Devices Ltd Inhaler
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010083042A1 (en) * 2009-01-15 2010-07-22 Manta Devices, Llc Delivery device
NZ574666A (en) * 2009-02-05 2009-04-30 Nexus6 Ltd A medicament inhaler holder that uses optical means to count and display the number of doses used
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
FR2946537B1 (en) * 2009-06-11 2012-08-03 Valois Sas INHALATION DEVICE FOR POWDER
KR101875969B1 (en) 2009-06-12 2018-07-06 맨카인드 코포레이션 Diketopiperazine microparticles with defined specific surface areas
RU2536826C2 (en) 2009-07-01 2014-12-27 Астразенека Аб Delivery device and method for increasing powder supply into air flow
RU2563809C2 (en) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Using levofloxacin in aerosol form for treating mucoviscidosis
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
WO2011080761A1 (en) 2009-12-30 2011-07-07 Thirumalai Anadampillai Aparna An improved dry powder inhaler
CN104338219B (en) 2010-01-05 2017-10-24 微剂量治疗技术公司 inhalation device and method
EP2531096A4 (en) 2010-02-01 2013-09-11 Proteus Digital Health Inc Two-wrist data gathering system
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
WO2011116293A2 (en) 2010-03-19 2011-09-22 Manta Devices, Llc Delivery device and related methods
RU2571331C1 (en) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Systems and methods for dry powder drug delivery
US20140000601A1 (en) * 2010-07-21 2014-01-02 Astrazeneca Ab Inhaler
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
BR122020008875B8 (en) 2011-04-01 2022-12-06 Mannkind Corp BLISTER PACKAGING AND METHOD OF MANUFACTURING A BLISTER PACKAGE
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US11103659B2 (en) 2011-07-06 2021-08-31 Manta Devices, Llc Delivery device and related methods
CA2852536A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
US9649454B2 (en) 2012-05-03 2017-05-16 Manta Devices, Llc Delivery device and related methods
EA030019B1 (en) * 2012-05-25 2018-06-29 Арвен Айлак Санайи Ве Тиджарет А.С. Trigger mechanism for inhaler device
KR102264177B1 (en) 2012-07-12 2021-06-11 맨카인드 코포레이션 Dry powder drug delivery systems and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
BR112015023168B1 (en) 2013-03-15 2021-08-10 Mannkind Corporation COMPOSITION OF 3,6-BIS(N-FUMARYL-4-AMINOBUTYL)-2,5-CRYSTALLINE DICETOPIPERAZINE, METHOD OF PRODUCTION OF 3,6-BIS(N-FUMARYL-4-AMINOBUTYL)-2,5-DICETOPIPERAZINE PARTICLES AND USE OF A CRYSTALLINE DICETOPIPERAZINE COMPOSITION
CN114848614A (en) 2013-07-18 2022-08-05 曼金德公司 Heat stable dry powder pharmaceutical compositions and methods
EP3027026A4 (en) 2013-07-31 2017-05-03 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
NZ760541A (en) 2014-01-10 2022-08-26 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US11147936B2 (en) 2014-05-02 2021-10-19 Manta Devices, Llc Dose delivery device with cover connected to dose chamber seal
US9895500B2 (en) * 2014-07-24 2018-02-20 Hcmed Innovations Co., Ltd. Portable ultrasonic nebulizer and medicine accommodating structure thereof
TWI566795B (en) * 2014-07-24 2017-01-21 心誠鎂行動醫電股份有限公司 Portable ultrasonic nebulizer and protection structure thereof
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307734A (en) * 1980-06-23 1981-12-29 B & B Inventors & Marketers, Inc. Snuff dispenser
US4778054A (en) * 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
GR79615B (en) * 1982-10-08 1984-10-31 Glaxo Group Ltd
GB8314308D0 (en) * 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
CH672600A5 (en) * 1985-07-30 1989-12-15 Glaxo Group Ltd
US4971221A (en) * 1988-11-23 1990-11-20 Aprex Corporation Drug dispenser having means for detecting dispensing events
IT1230313B (en) * 1989-07-07 1991-10-18 Somova Spa INHALER FOR CAPSULES MEDICATIONS.
IT1237118B (en) * 1989-10-27 1993-05-18 Miat Spa MULTI-DOSE INHALER FOR POWDER DRUGS.
DK544589D0 (en) * 1989-11-01 1989-11-01 Novo Nordisk As MANUALLY OPERATED DEVICE FOR DISPENSING A PRESCRIBED QUANTITY OF A POWDER-SHAPED SUBSTANCE
US5113855A (en) * 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
US5201308A (en) * 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
IT1243344B (en) * 1990-07-16 1994-06-10 Promo Pack Sa MULTI-DOSE INHALER FOR POWDER MEDICATIONS
US5492112A (en) * 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5327883A (en) * 1991-05-20 1994-07-12 Dura Pharmaceuticals, Inc. Apparatus for aerosolizing powdered medicine and process and using
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5469843A (en) * 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
CZ282964B6 (en) * 1992-10-19 1997-11-12 Dura Pharmaceuticals, Inc. Apparatus for making aerosol from a pulverized medicament
HU216405B (en) * 1993-03-03 1999-06-28 Tenax Corp. Dry powder inhalator medicament carrier
US5349947A (en) * 1993-07-15 1994-09-27 Newhouse Michael T Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
CA2172952A1 (en) * 1993-10-28 1995-05-04 Michael Leonard Mckay Improvements relating to formation and delivery of an atomised liquid
CA2555600C (en) * 1994-09-21 2008-01-29 Nektar Therapeutics Apparatus and methods for dispersing dry powder medicaments
US5645051A (en) * 1995-04-21 1997-07-08 Dura Pharmaceuticals, Inc. Unit dose dry powder inhaler
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054646A1 (en) * 2002-12-18 2004-07-01 Quadrant Technologies Limited Unit dose dry powder inhaler
US6941947B2 (en) 2002-12-18 2005-09-13 Quadrant Technologies Limited Unit dose dry powder inhaler
US20050252510A1 (en) * 2002-12-18 2005-11-17 Quadrant Technologies Limited Unit dose dry powder inhaler
US20040118399A1 (en) * 2002-12-18 2004-06-24 Elan Pharmaceutical Technologies Unit dose dry powder inhaler
US7617822B2 (en) 2003-06-16 2009-11-17 Rijksuniversiteit Groningen Dry powder inhaler and method for pulmonary inhalation of dry powder
US8161968B2 (en) 2003-07-24 2012-04-24 Glaxo Group Limited Medicament dispenser
US8997737B2 (en) 2003-10-17 2015-04-07 Vectura Delivery Devices Limited Inhaler
US20070221218A1 (en) * 2003-10-27 2007-09-27 Warden Jeffrey A Dry Powder Drug Containment System Packages with Tabs, Inhalers and Associated Methods
US20050126562A1 (en) * 2003-12-15 2005-06-16 Alexza Molecular Delivery Corporation Treatment of breakthrough pain by drug aerosol inhalation
US9016273B2 (en) * 2004-02-19 2015-04-28 Akihiko Miyamoto Inhaler aid with reed for minute powdery curative medicine
US20070272235A1 (en) * 2004-02-19 2007-11-29 Akihiko Miyamoto Inhaler Aid With Reed for Minute Powdery Curative Medicine
US9333310B2 (en) 2004-08-16 2016-05-10 Glaxo Group Limited Medicament dispenser
US20080041368A1 (en) * 2004-08-16 2008-02-21 Glaxo Group Limited Medicament Dispenser
US8201556B2 (en) * 2004-08-16 2012-06-19 Glaxo Group Limited Medicament dispenser
US8746242B2 (en) 2005-07-28 2014-06-10 Glaxo Group Limited Medicament dispenser
US20080196718A1 (en) * 2005-07-28 2008-08-21 Glaxo Group Limited Medicament Dispenser
US20070154407A1 (en) * 2005-12-01 2007-07-05 Boehringer Ingelheim International Gmbh Inhaler and store for a dry medicament formulation and related methods and use thereof
US9463290B2 (en) 2006-05-18 2016-10-11 Boehringer Ingelheim International Gmbh Atomizer
US8813743B2 (en) * 2006-05-18 2014-08-26 Boehringer Ingelheim International Gmbh Atomizer
US20070267015A1 (en) * 2006-05-18 2007-11-22 Boehringer Ingelheim International Gmbh Atomizer
US8776788B2 (en) 2006-11-15 2014-07-15 Glaxo Group Limited Sheet driver for use in a drug dispenser
US20100059052A1 (en) * 2006-11-15 2010-03-11 Glaxo Group Limited Sheet driver for use in a drug dispenser
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
US20110094510A1 (en) * 2008-01-24 2011-04-28 Vectura Delivery Devices Limited Inhaler
CN101980742A (en) * 2008-01-24 2011-02-23 维克多瑞传送设备有限公司 Inhaler
EP2082772A1 (en) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
RU2481129C2 (en) * 2008-01-24 2013-05-10 Вектура Деливери Дивайсиз Лимитед Inhaler
WO2009092770A1 (en) * 2008-01-24 2009-07-30 Vectura Delivery Devices Limited Inhaler
US20110162648A1 (en) * 2008-09-26 2011-07-07 Ruckdeschel Thomas W Inhaler mechanisms with radially biased piercers and related methods
US8550071B2 (en) 2008-09-26 2013-10-08 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
US8985103B2 (en) 2008-09-26 2015-03-24 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members
US8381721B2 (en) 2008-09-26 2013-02-26 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and related devices and methods
US8671938B2 (en) 2008-09-26 2014-03-18 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
US9597465B2 (en) 2008-09-26 2017-03-21 Oriel Therapeutics, Inc. Methods of operating and fabricating inhalers with airway disks having discrete airway channels
US9795749B2 (en) 2008-09-26 2017-10-24 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and methods of operating same
US10493222B2 (en) 2008-09-26 2019-12-03 Oriel Therapeutics, Inc. Dry powder dose container assemblies and related inhalers
US20100078022A1 (en) * 2008-09-26 2010-04-01 Rachel Striebig Inhalers with airway disks having discrete airway channels and related disks and methods
US8887722B2 (en) 2008-09-26 2014-11-18 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
US9050427B2 (en) 2008-09-30 2015-06-09 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
US20110174306A1 (en) * 2008-09-30 2011-07-21 David Harris Dry Powder Inhalers with Multi-Facet Surface Deagglomeration Chambers and Related Devices and Methods
US8646446B2 (en) 2008-10-01 2014-02-11 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
US20110186047A1 (en) * 2008-10-01 2011-08-04 Scott Alexander Lewis Dry Powder Inhalers with Rotating Piercing Mechanisms and Related Devices and Methods
USD685461S1 (en) 2010-03-26 2013-07-02 Oriel Therapeutics, Inc. Dose disk for a dry powder inhaler
USD745660S1 (en) 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
USD684684S1 (en) 2010-03-26 2013-06-18 Oriel Therapeutics, Inc. Dry powder inhaler
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD711528S1 (en) 2010-03-26 2014-08-19 Oriel Therapeutics, Inc. Dry powder inhaler
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
US11471623B2 (en) 2012-02-21 2022-10-18 Respira Therapeutics, Inc. Powder dispersion methods and devices
US10441733B2 (en) 2012-06-25 2019-10-15 Respira Therapeutics, Inc. Powder dispersion devices and methods
WO2014004256A1 (en) * 2012-06-25 2014-01-03 Respira Therapeutics, Inc. Powder dispersion devices and methods
US11040156B2 (en) 2015-07-20 2021-06-22 Pearl Therapeutics, Inc. Aerosol delivery systems
USD852408S1 (en) 2016-02-08 2019-06-25 Nicoventures Holdings Limited Electronic cigarette
US11123501B2 (en) 2016-03-24 2021-09-21 Nicoventures Holdings Limited Electronic vapor provision system
US11213638B2 (en) 2016-03-24 2022-01-04 Nicoventures Trading Limited Vapor provision system
US11241043B2 (en) 2016-03-24 2022-02-08 Nicoventures Trading Limited Vapor provision apparatus
US11452826B2 (en) 2016-03-24 2022-09-27 Nicoventures Trading Limited Mechanical connector for electronic vapor provision system
US11524823B2 (en) 2016-07-22 2022-12-13 Nicoventures Trading Limited Case for a vapor provision device

Also Published As

Publication number Publication date
US6328034B1 (en) 2001-12-11
NZ333685A (en) 2000-09-29
BR9710880A (en) 1999-08-17
EP0925084A1 (en) 1999-06-30
IL128030A0 (en) 1999-11-30
HUP9903819A3 (en) 2001-02-28
AU729272B2 (en) 2001-02-01
WO1998003217A1 (en) 1998-01-29
JP2001507949A (en) 2001-06-19
NZ505722A (en) 2001-03-30
US5921237A (en) 1999-07-13
AU3646697A (en) 1998-02-10
EP0925084A4 (en) 2001-01-31
HUP9903819A2 (en) 2000-03-28
NO990272L (en) 1999-03-22
NO990272D0 (en) 1999-01-21
CZ18999A3 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
US6328034B1 (en) Dry powder inhaler
WO1998003217A9 (en) Dry powder inhaler
EP0028162B1 (en) Breath actuated devices for administering powdered medicaments
US6273085B1 (en) Dry powder inhaler
AU746970B2 (en) Dry powder inhaler
US7069929B2 (en) Dry powder inhaler
US6941947B2 (en) Unit dose dry powder inhaler
US5492112A (en) Dry powder inhaler
US6029662A (en) Compressed-air powder inhaler
AU695051B2 (en) Dry powder inhaler delivery system
JP2006502759A (en) Powder inhaler
EP1748813A1 (en) Unit dose dry powder inhales
GB2061735A (en) Breath actuated device for administration of powdered medicaments by inhalation
AU740035B2 (en) Dry powder inhaler
CA2261172A1 (en) Dry powder inhaler
MXPA99000824A (en) Dust inhaler s
MXPA00005436A (en) Dry powder inhaler

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION